本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nutriband Inc.

6.28
-0.3750-5.64%
成交量:1.00万
成交额:6.44万
市值:7,639.74万
市盈率:-10.93
高:6.57
开:6.57
低:6.18
收:6.65
52周最高:9.19
52周最低:2.80
股本:1,217.49万
流通股本:542.12万
量比:0.37
换手率:0.18%
股息:- -
股息率:- -
每股收益(TTM):-0.5739
每股收益(LYR):-2.5809
净资产收益率:-100.75%
总资产收益率:-53.48%
市净率:14.34
市盈率(LYR):-2.43

数据加载中...

公司资料

公司名字:
Nutriband Inc.
交易所:
NASDAQ
成立时间:
2016
员工人数:
- -
公司地址:
121 South Orange Avenue,Suite 1500,Orlando,Florida,United States
邮编:
32801
电话:
传真:
- -
简介:
Nutriband Inc.是一家内华达州公司,成立于2016年1月4日。他们主要从事透皮药物产品组合的开发。他们的主要产品是他们的滥用威慑芬太尼透皮系统,他们正在开发为临床医生和患者提供一种缓释芬太尼透皮产品,用于治疗需要全天候阿片类药物治疗的慢性疼痛,并结合旨在通过阻止滥用和误用芬太尼贴片来帮助对抗阿片类药物危机的特性。

董事

名称
职位
Gareth Sheridan
Chief Executive Officer and Director
Serguei Melnik
Chairman of the Board and Director and President and Secretary
Alessandro Puddu
Independent Director
Irina Gram
Independent Director
Mark Hamilton
Independent Director
Radu Bujoreanu
Independent Director
Sergei Glinka
Independent Director
Stefani Mancas
Independent Director
Viorica Carlig
Independent Director

股东

名称
职位
Gareth Sheridan
Chief Executive Officer and Director
Alan Smith
Chief Operating Officer and President of 4P Therapeutics
Gerald Goodman
Chief Accounting Officer and Chief Financial Officer
Jeff Patrick
Chief Scientific Officer
Serguei Melnik
Chairman of the Board and Director and President and Secretary